Cargando…

PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY

Detalles Bibliográficos
Autores principales: Fattizzo, Bruno, Vercellati, Cristina, Marcello, Anna, Patel, Parija, Wind-Rotolo, Megan, Pettine, Loredana, Leoni, Simona, Fermo, Elisa, Bianchi, Paola, Zaninoni, Anna, Barcellini, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430058/
http://dx.doi.org/10.1097/01.HS9.0000974776.07083.ab
_version_ 1785090862888255488
author Fattizzo, Bruno
Vercellati, Cristina
Marcello, Anna
Patel, Parija
Wind-Rotolo, Megan
Pettine, Loredana
Leoni, Simona
Fermo, Elisa
Bianchi, Paola
Zaninoni, Anna
Barcellini, Wilma
author_facet Fattizzo, Bruno
Vercellati, Cristina
Marcello, Anna
Patel, Parija
Wind-Rotolo, Megan
Pettine, Loredana
Leoni, Simona
Fermo, Elisa
Bianchi, Paola
Zaninoni, Anna
Barcellini, Wilma
author_sort Fattizzo, Bruno
collection PubMed
description
format Online
Article
Text
id pubmed-10430058
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104300582023-08-17 PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY Fattizzo, Bruno Vercellati, Cristina Marcello, Anna Patel, Parija Wind-Rotolo, Megan Pettine, Loredana Leoni, Simona Fermo, Elisa Bianchi, Paola Zaninoni, Anna Barcellini, Wilma Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430058/ http://dx.doi.org/10.1097/01.HS9.0000974776.07083.ab Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Fattizzo, Bruno
Vercellati, Cristina
Marcello, Anna
Patel, Parija
Wind-Rotolo, Megan
Pettine, Loredana
Leoni, Simona
Fermo, Elisa
Bianchi, Paola
Zaninoni, Anna
Barcellini, Wilma
PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
title PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
title_full PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
title_fullStr PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
title_full_unstemmed PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
title_short PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
title_sort pb1990: glycolytic activity and effect of ex-vivo treatment with the pyruvate kinase (pk) activator ag-946 in red blood cells from low-risk myelodysplastic syndromes patients: a proof-of-concept study
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430058/
http://dx.doi.org/10.1097/01.HS9.0000974776.07083.ab
work_keys_str_mv AT fattizzobruno pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT vercellaticristina pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT marcelloanna pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT patelparija pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT windrotolomegan pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT pettineloredana pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT leonisimona pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT fermoelisa pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT bianchipaola pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT zaninonianna pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy
AT barcelliniwilma pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy